SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The 56 Point TA; Charts With an Attitude

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug R who wrote (3000)9/3/1997 3:57:00 PM
From: arnold silver   of 79269
 
Hi Doug,
I mentioned to you I was going north and would look into GELX
Well the president CEO was out of town and I talked to a gentleman
named Paul Millett .I wanted a face to face but he was leaving town
But he was very willing to talk .
Iquestioned him about why they hired 4 new executives ,
They are there for their new medication RENA GEL,sales and manufacture.I questioned him about the FDA approval and he seemed to think it is a sure thing.GENZYME is a 50% partner
(for about 50 million)This company is building equipment for the manufacturing of this product ,so when they get approval the fda
( at the same time) approves the facilities,
World wide there are 400,000 people on dialysis they all will use this
rena gel the figure per patient is $1000 to $1500 per year.You work out the numbers.September is when they will submit to fda.
The burn rate is $15 million a year.$62 million in the bank.More to come from GENZ .There are 6 things in the pipeline ,a cholsterol
thing is in phase 2 .
If any thing else comes to my mind i shall report .
You can check into more than I can explain by their last 4 or 5 news releases.
Enjoy
Arnie
BTW you did great on the cade moves and also seeq
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext